Akin Gump Advises Baker Bros. Advisors LP in Exact Sciences Acquisition of Genomic Health
Contact:
(New York) – Akin Gump advised Baker Bros. Advisors LP, the largest shareholder in Genomic Health, Inc., in the planned $2.8 billion sale of Genomic Health to Exact Sciences Corp.
Under the terms of the deal, Genomic Health stockholders will receive $27.50 per share in cash and $44.50 in Exact Sciences stock. The transaction, which was unanimously approved by the boards of directors of both companies, is expected to close by the end of 2019.
Genomic Health is the world’s leading provider of genomic-based diagnostic tests that help optimize cancer care, including addressing the overtreatment of the disease. Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer.
Jeffrey Kochian, head of Akin Gump’s corporate practice, led the team advising Baker Bros. He was joined by counsel Alyssa Dossick.
Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
# # #